Thermo Fisher Scientific

Articles by Thermo Fisher Scientific

Technology Forum Series: Strategies to Prevent Drug Shortages and Resolve Capacity Challenges

***Session 1: Thursday, April 22, 2021, 10am EDT, Session 2: Thursday, April 22, 2021, 11am EDT, Session 3: Thursday, April 22, 2021, 1pm EDT*** A drug’s journey from development to manufacturing to patients is paved with roadblocks and potholes; many threats can derail bio/pharmaceutical processes. Potential solutions to such pitfalls have been discussed for years; however, few manufacturers have embraced technology and process advances to proactively ensure drug supply chain continuity.

2020 Bio/Pharma Virtual Congress

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021

Capable and Compliant XRD in Pharmaceutical Analysis

*** Live: Thursday, October 22, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Be sure you’re using the latest XRD sample preparation and measurement strategies while confidently meeting audit trail and compliance requirements. Learn how recent software solutions enable straightforward, compliant pharmaceutical workflows. ***On demand available after final airing until Oct. 22, 2021***

Listen and learn as Dr. James Grinias from Rowan University and Dr. Frank Steiner from Thermo Fisher Scientific discuss approaches and considerations to modernizing HPLC methods to increase throughput using superficially porous particles. They also discuss challenges in method transfer and describe new compliant hardware technologies built into the modern HPLC and UHPLC systems. Live: Tuesday, Aug. 25, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing until Aug. 25, 2021

ORC International’s report Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing explores causes, consequences, and potential solutions to forecasting challenges related to biopharmaceutical drug substance manufacturing. It provides insight and perspective on key themes that emerge from the report, offering additional solutions to prepare for inevitable forecast inaccuracies.

Elemental impurity analysis is vital for ensuring the safety of pharmaceutical products. With newly revised and modernized standards for elemental and organic impurities slated to take effect soon, developers must understand and be able to meet the newest analytical requirements. In this eBook, learn from experts at the US Pharmacopeia what drug companies need to know about USP and . Also learn about the use of atomic spectroscopy techniques and sample preparation procedures for elemental impurities analysis.